These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 2644091)

  • 41. Airway isocyanate-adducts in asthma induced by exposure to hexamethylene diisocyanate.
    Redlich CA; Karol MH; Graham C; Homer RJ; Holm CT; Wirth JA; Cullen MR
    Scand J Work Environ Health; 1997 Jun; 23(3):227-31. PubMed ID: 9243734
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acquired persistent increase in nonspecific bronchial, reactivity associated with isocyanate exposure.
    Cockcroft DW
    Ann Allergy; 1982 Feb; 48(2):93-5. PubMed ID: 7065472
    [No Abstract]   [Full Text] [Related]  

  • 43. Protective effect of antiasthma drugs on late asthmatic reactions and increased airway responsiveness induced by toluene diisocyanate in sensitized subjects.
    Mapp C; Boschetto P; dal Vecchio L; Crescioli S; de Marzo N; Paleari D; Fabbri LM
    Am Rev Respir Dis; 1987 Dec; 136(6):1403-7. PubMed ID: 2825567
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Specific bronchial reactivity to toluene diisocyanate: dose-response relationship.
    Paggiaro PL; Lastrucci L; Pardi F; Rossi O; Bacci E; Talini D
    Respiration; 1986; 50(3):167-73. PubMed ID: 3025984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bronchoalveolar lavage and morphology of the airways after cessation of exposure in asthmatic subjects sensitized to toluene diisocyanate.
    Paggiaro P; Bacci E; Paoletti P; Bernard P; Dente FL; Marchetti G; Talini D; Menconi GF; Giuntini C
    Chest; 1990 Sep; 98(3):536-42. PubMed ID: 2168308
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bronchoprovocation tests in the diagnosis of isocyanate-induced asthma.
    Banks DE; Tarlo SM; Masri F; Rando RJ; Weissman DN
    Chest; 1996 May; 109(5):1370-9. PubMed ID: 8625691
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New aspects of isocyanate asthma.
    Baur X
    Lung; 1990; 168 Suppl():606-13. PubMed ID: 2117170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ketotifen does not inhibit asthmatic reactions induced by toluene di-isocyanate in sensitized subjects.
    Tossin L; Chiesura-Corona P; Fabbri LM; De Marzo N; Picotti G; Crescioli S; Mapp CE
    Clin Exp Allergy; 1989 Mar; 19(2):177-82. PubMed ID: 2546659
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Occupational asthma without bronchial hyperresponsiveness.
    Hargreave FE; Ramsdale EH; Pugsley SO
    Am Rev Respir Dis; 1984 Sep; 130(3):513-5. PubMed ID: 6089628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significant changes in nonspecific bronchial responsiveness after isolated immediate bronchospecific reactions caused by isocyanates but not after a late reaction caused by plicatic acid.
    Malo JL; L'Archevêque J; Cartier A
    J Allergy Clin Immunol; 1989 Jan; 83(1):159-65. PubMed ID: 2643658
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Response to isocyanates: effect of concentration, duration of exposure, and dose.
    Vandenplas O; Cartier A; Ghezzo H; Cloutier Y; Malo JL
    Am Rev Respir Dis; 1993 May; 147(5):1287-90. PubMed ID: 8387256
    [TBL] [Abstract][Full Text] [Related]  

  • 52. You're the flight surgeon. Isocyanates are the most common cause of occupational asthma.
    Hrncir DE
    Aviat Space Environ Med; 1990 Aug; 61(8):765-6. PubMed ID: 2400387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Closed-circuit methodology for inhalation challenge tests with isocyanates.
    Vandenplas O; Malo JL; Cartier A; Perreault G; Cloutier Y
    Am Rev Respir Dis; 1992 Mar; 145(3):582-7. PubMed ID: 1546838
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure.
    Park HS; Nahm DH
    Clin Exp Allergy; 1997 Oct; 27(10):1145-50. PubMed ID: 9383254
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Absence of airway hyperreactivity to methacholine in a worker sensitized to toluene diisocyanate (TDI).
    Smith AB; Brooks SM; Blanchard J; Bernstein IL; Gallagher J
    J Occup Med; 1980 May; 22(5):327-31. PubMed ID: 6247471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and socio-professional fate of isocyanate-induced asthma.
    Rosenberg N; Garnier R; Rousselin X; Mertz R; Gervais P
    Clin Allergy; 1987 Jan; 17(1):55-61. PubMed ID: 3829371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term effects on the health of men engaged in the manufacture of tolylene di-isocyanate.
    Adams WG
    Br J Ind Med; 1975 Feb; 32(1):72-8. PubMed ID: 164881
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Respiratory health surveillance in a toluene di-isocyanate production unit, 1967-97: clinical observations and lung function analyses.
    Ott MG; Klees JE; Poche SL
    Occup Environ Med; 2000 Jan; 57(1):43-52. PubMed ID: 10711268
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Bronchial asthma caused by isocyanate in the internal/external environment].
    Rasmussen K; Dahl R
    Ugeskr Laeger; 1989 May; 151(19):1193-5. PubMed ID: 2544056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recurrent nocturnal asthma due to tolylene di-isocyanate: a case report.
    Siracusa A; Curradi F; Abbritti G
    Clin Allergy; 1978 Mar; 8(2):195-201. PubMed ID: 206384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.